Recently, we reported that activation of the nuclear receptor FXR prevents inflammation in animal models of IBD with improvement of colitis symptoms, preservation of the intestinal epithelial barrier function and reduction of goblet cell loss [17]. The gene discussed is NR1H4; the disease is inflammatory bowel disease.